Funds holding Invivyd Inc
ISIN US00534A1025 · United States
- Fund holders
- 31
- Of which ETFs
- 5 26 other funds
- Value held
- 39.9M $
- Share of capital
- 10.1 % of 294.8M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 9,071,995 | 11.8M $ | 0.74 % | 3.08 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 7,392,820 | 9.6M $ | 0.00 % | 2.51 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 5,654,625 | 7.4M $ | 0.10 % | 1.92 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,371,004 | 3.1M $ | 0.00 % | 0.80 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 921,688 | 1.6M $ | 0.00 % | 0.31 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 571,661 | 743.2K $ | 0.00 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 562,019 | 730.6K $ | 0.16 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 428,847 | 600.4K $ | 0.04 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Adara Smaller Companies Fund RBB Fund, Inc. | 386,139 | 652.6K $ | 0.09 % | 0.13 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 363,923 | 509.5K $ | 0.02 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 339,312 | 573.4K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 329,668 | 461.5K $ | 0.09 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 272,505 | 460.5K $ | 0.00 % | 0.09 % | as of Feb 28, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 172,414 | 224.1K $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 160,152 | 270.7K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 142,837 | 241.4K $ | 0.03 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 136,616 | 177.6K $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 118,970 | 166.6K $ | 0.45 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 117,920 | 165.1K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 102,029 | 142.8K $ | 0.08 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 93,400 | 121.4K $ | 0.10 % | 0.03 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 45,294 | 58.9K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 31,477 | 40.9K $ | 0.10 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 25,703 | 36K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 20,809 | 27.1K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 15,472 | 26.1K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 12,796 | 21.6K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 12,100 | 15.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 4,475 | 5.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 2,516 | 3.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 1,289 | 1.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.74 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.45 % | as of Apr 30, 2026 ↗ |
| Driehaus Micro Cap Growth Fund Driehaus Mutual Funds | 0.16 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.10 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.10 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.10 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 0.09 % | as of Apr 30, 2026 ↗ |
| Adara Smaller Companies Fund RBB Fund, Inc. | 0.09 % | as of Feb 28, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 0.08 % | as of Apr 30, 2026 ↗ |
| Emerald Growth Fund FINANCIAL INVESTORS TRUST | 0.04 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 31 | +5 | 29,882,475 | +29.2 % |
| 2026Q1 | 26 | +11 | 23,130,001 | +252.3 % |
| 2025Q4 | 15 | -21 | 6,565,702 | +10.6 % |
| 2025Q3 | 36 | -30 | 5,936,322 | -48.7 % |
| 2025Q2 | 66 | -1 | 11,571,424 | -5.1 % |
| 2025Q1 | 67 | -8 | 12,191,902 | -8.3 % |
| 2024Q4 | 75 | +26 | 13,297,977 | +30.5 % |
| 2024Q3 | 49 | +15 | 10,187,147 | +33.9 % |
| 2024Q2 | 34 | +11 | 7,609,450 | +5.4 % |
| 2024Q1 | 23 | -2 | 7,221,559 | -12.5 % |
| 2023Q4 | 25 | 8,252,512 |
Institutional managers
136 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 33,094,330 | 42.9M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 20,859,303 | 27.1M $ | as of Mar 31, 2026 |
| BVF INC/IL | 19,525,000 | 25.4M $ | as of Mar 31, 2026 |
| MAVERICK CAPITAL LTD | 18,970,913 | 24.7M $ | as of Mar 31, 2026 |
| Saturn V Capital Management LP | 10,949,084 | 14.2M $ | as of Mar 31, 2026 |
| M28 Capital Management LP | 9,248,250 | 12M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 9,071,995 | 11.8M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 8,436,894 | 11M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 7,708,727 | 10M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,935,648 | 9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 4,281,790 | 5.6M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 4,000,000 | 5.2M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 3,822,427 | 5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,661,480 | 4.8M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 3,515,644 | 4.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,511,581 | 4.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,388,182 | 4.4M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 2,687,195 | 3.5M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 2,656,570 | 3.5M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 2,648,659 | 3.4M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,611,445 | 3.4M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 2,515,000 | 3.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,468,927 | 3.2M $ | as of Mar 31, 2026 |
| Eversept Partners, LP | 2,276,349 | 3M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 2,019,207 | 2.6M $ | as of Mar 31, 2026 |
Declared shareholders of Invivyd Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 3 others | 7.00 % | 21,342,442 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.00 % | 43,931 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Invivyd Inc". https://titelia.com/en/stocks/invivyd-inc-US00534A1025